Breaking News Headlines Today

News about Wegovy

Stay current with all the latest and breaking news about Wegovy, compare headlines and perspectives between news sources on stories happening today. In total, 118 stories have been published about Wegovy which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Wegovy News

Eli Lilly · United States

Wegovy® Approved by FDA for the Treatment of Adults with Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis

54% Center coverage: 39 sources

Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver, in conjunction with a reduced calorie diet and increased physical…See the Story

Pharma · Denmark

September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO - Novo Nordisk (NYSE:NVO)

56% Center coverage: 32 sources

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE:NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-s…See the Story

Diabetes · Indianapolis

Eli Lilly's experimental Mounjaro pill showcases promising weight loss results

66% Center coverage: 12 sources

NHS Makes Weight Loss Jab Guidance Change Including Wegovy and Mounjaro - 'It's Crucial'

46% Left coverage: 11 sources

It's estimated 1.5 million people across Britain are taking medication to help them lose weightEurope · Scotland See the Story

'King Kong' weight loss jab Mounjaro hit by NHS postcode lottery

50% Left coverage: 6 sources

NHS · England See the Story

Wegovy and Zepbound patients are resorting to these cost-saving measures to stay on the weight-loss drugs

100% Left coverage: 1 sources

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but as more U.S. insurers restrict coverage people are trimming costs by stretching doses or forgoing expenditures like vacations to pay for the medication out of pocket. A half dozen doctors who spoke with Reuters said insurance coverage has tightened in 2025 as many employers drop it for the expensive GLP-1 drugs. While patie…Medical · United States See the Story

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

Coverage: 2 sources

By Maggie Fick and Diana Novak JonesWegovy · United States See the Story

Tricare ending coverage of popular weight loss drugs for some retirees, other patients

100% Center coverage: 1 sources

tricare will no longer cover weight loss drugs such as zepbound, wegovy or other glp-1 medications.Wegovy · United States Read Article

Novo keeps the lead in obesity pill battle against Lilly

Eli Lilly’s injectable obesity drug Zepbound has been proven more effective than Novo Nordisk’s Wegovy. But in the battle of the pills, it appears to be the other way around. Lilly on ...Wegovy Read Article

Some Wegovy prescriptions redirected to pharmacies that signed exclusive deals with insurers

100% Center coverage: 1 sources

It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNsWegovy · Canada Read Article

Novo Pushes Back Against Obesity Drug Compounders as Competition Intensifies

100% Center coverage: 2 sources

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.Diabetes See the Story

News about Wegovy

News about Wegovy

Covered Most By

Local News Publishers

Top Wegovy News

Wegovy® Approved by FDA for the Treatment of Adults with Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis

September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO - Novo Nordisk (NYSE:NVO)

Eli Lilly's experimental Mounjaro pill showcases promising weight loss results

NHS Makes Weight Loss Jab Guidance Change Including Wegovy and Mounjaro - 'It's Crucial'

'King Kong' weight loss jab Mounjaro hit by NHS postcode lottery

Wegovy and Zepbound patients are resorting to these cost-saving measures to stay on the weight-loss drugs

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

Tricare ending coverage of popular weight loss drugs for some retirees, other patients

Novo keeps the lead in obesity pill battle against Lilly

Some Wegovy prescriptions redirected to pharmacies that signed exclusive deals with insurers

Novo Pushes Back Against Obesity Drug Compounders as Competition Intensifies

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Wegovy

NHS Makes Weight Loss Jab Guidance Change Including Wegovy and Mounjaro - 'It's Crucial'

'King Kong' weight loss jab Mounjaro hit by NHS postcode lottery

Wegovy and Zepbound patients are resorting to these cost-saving measures to stay on the weight-loss drugs

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

Tricare ending coverage of popular weight loss drugs for some retirees, other patients

Novo keeps the lead in obesity pill battle against Lilly

Some Wegovy prescriptions redirected to pharmacies that signed exclusive deals with insurers

Novo Pushes Back Against Obesity Drug Compounders as Competition Intensifies